Skip to main content
Have a personal or library account? Click to login
An Approach to Overcome the Limitations of Surveillance of Asbestos Related Diseases in Low- and Middle-Income Countries: What We Learned from the Sibaté Study in Colombia Cover

An Approach to Overcome the Limitations of Surveillance of Asbestos Related Diseases in Low- and Middle-Income Countries: What We Learned from the Sibaté Study in Colombia

Open Access
|Oct 2023

References

  1. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans, volume 100 C. A review of human carcinogens: Arsenic, Metals, Fibres, and Dusts. Lyon, France: IARC; 2012 Accessed December 12, 2022. https://monographs.iarc.fr/wp-content/uploads/2018/06/mono100C.pdf.
  2. International Asbestos Secretariat. Current asbestos bans. Accessed December 12, 2022. http://www.ibasecretariat.org/alpha_ban_list.php.
  3. Ministerio de Ambiente. Ley 1968 de 2019.
  4. Lysaniuk B, Cely-García MF, Giraldo M, et al. Using GIS to Estimate Population at Risk Because of Residence Proximity to Asbestos Processing Facilities in Colombia. Int J Environ Res Public Health. 2021; 18(24). DOI: 10.3390/ijerph182413297
  5. Ramos-Bonilla JP, Cely-García MF, Giraldo M, et al. An asbestos contaminated town in the vicinity of an asbestos-cement facility: The case study of Sibaté, Colombia. Environ Res. 2019; 176(January): 108464. DOI: 10.1016/j.envres.2019.04.031
  6. Cely-García MF, Lysaniuk B, Pasetto R, Ramos-Bonilla JP. The challenges of applying an Activity-Based Sampling methodology to estimate the cancer risk associated with asbestos contaminated landfilled zones. Environ Res. 2020; 181: 108893. DOI: 10.1016/j.envres.2019.108893
  7. Lysaniuk B, Cely-García MF, Mazzeo A, et al. Where are the landfilled zones? Use of historical geographic information and local spatial knowledge to determine the location of underground asbestos contamination in Sibaté (Colombia). Environ Res. 2020; 191: 110182. DOI: 10.1016/j.envres.2020.110182
  8. Fazzo L, De Santis M, Minelli G, et al. Pleural mesothelioma mortality and asbestos exposure mapping in Italy. Am J Ind Med. 2012; 55(1): 1124. DOI: 10.1002/ajim.21015
  9. Fazzo L, Minelli G, De Santis M, et al. Mesothelioma mortality surveillance and asbestos exposure tracking in Italy. Ann Ist Super Sanita. 2012; 48(3): 300310. DOI: 10.4415/ANN_12_03_11
  10. Gatto MP, Tanna D. Distribution and trends in mesothelioma mortality in Italy from 1974 to 2006. Int Arch Occup Environ Health. 2013; 86(4): 489496. DOI: 10.1007/s00420-012-0780-6
  11. Marinaccio A, Scarselli A, Binazzi A, et al. Asbestos related diseases in Italy: an integrated approach to identify unexpected professional or environmental exposure risks at municipal level. Int Arch Occup Environ Health. 2008; 81(8): 9931001. DOI: 10.1007/s00420-007-0293-x
  12. Magnani C, Dalmasso P, Biggeri A, Ivaldi C, Mirabelli D, Terracini B. Increased risk of malignant mesothelioma of the pleura after residential or domestic exposure to asbestos: a case-control study in Casale Monferrato, Italy. Environ Health Perspect. 2001; 109(9): 915919. DOI: 10.1289/ehp.01109915
  13. Magnani C, Terracini B, Ivaldi C, et al. A cohort study on mortality among wives of workers in the asbestos cement industry in Casale Monferrato, Italy. Br J Ind Med. 1993; 50(9): 779784. DOI: 10.1136/oem.50.9.779
  14. Van den Borre L, Deboosere P. Asbestos in Belgium: an underestimated health risk. The evolution of mesothelioma mortality rates (1969–2009). Int J Occup Environ Health. 2014; 20(2): 134140. DOI: 10.1179/2049396714Y.0000000058
  15. Burdorf A, Siesling S, Sinninghe Damsté HEJ. Regionale Spreiding van Het Maligne Mesothelioom in Nederland: Deelrapport 1; 2005.
  16. Mak V, Davies E, Putcha V, Choodari-Oskooei B, Møller H. The epidemiology and treatment of mesothelioma in South East England 1985–2002. Thorax. 2008; 63(2): 160166. DOI: 10.1136/thx.2006.066886
  17. Schonfeld SJ, McCormack V, Rutherford MJ, Schüz J. Regional variations in German mesothelioma mortality rates: 2000–2010. Cancer Causes Control. 2014; 25(5): 615624. DOI: 10.1007/s10552-014-0368-4
  18. López-Abente G, Hernández-Barrera V, Pollán M, Aragonés N, Pérez-Gómez B. Municipal pleural cancer mortality in Spain. Occup Environ Med. 2005; 62(3): 195199. DOI: 10.1136/oem.2004.015743
  19. García-Gómez M, Menéndez-Navarro A, López RC. Asbestos-related occupational cancers compensated under the Spanish National Insurance System, 1978–2011. Int J Occup Environ Health. 2015; 21(1): 3139. DOI: 10.1179/2049396714Y.0000000087
  20. Skammeritz E, Omland Ø, Hansen J, Johansen JP. Regional differences in incidence of malignant mesothelioma in Denmark. Dan Med J. 2013; 60(3): A4592.
  21. Algranti E, Saito CA, Carneiro APS, Moreira B, Mendonça EMC, Bussacos MA. The next mesothelioma wave: mortality trends and forecast to 2030 in Brazil. Cancer Epidemiol. 2015; 39(5): 687692. DOI: 10.1016/j.canep.2015.08.007
  22. Noonan CW, Conway K, Landguth EL, et al. Multiple pathway asbestos exposure assessment for a Superfund community. J Expo Sci Environ Epidemiol. 2015; 25(1): 1825. DOI: 10.1038/jes.2014.25
  23. Driscoll RJ, Mulligan WJ, Schultz D, Candelaria A. Malignant mesothelioma. A cluster in a native American pueblo. N Engl J Med. 1988; 318(22): 14371438. DOI: 10.1056/NEJM198806023182205
  24. Lewinsohn HC, Meigs JW, Teta MJ, Flannery JT. The influence of occupational and environmental asbestos exposure on the incidence of malignant mesothelioma in Connecticut. IARC Sci Publ. 1980; 30: 655660.
  25. Pan X lei, Day HW, Wang W, Beckett LA, Schenker MB. Residential proximity to naturally occurring asbestos and mesothelioma risk in California. Am J Respir Crit Care Med. 2005; 172(8): 10191025. DOI: 10.1164/rccm.200412-1731OC
  26. Berry M. Mesothelioma incidence and community asbestos exposure. Environ Res. 1997; 75(1): 3440. DOI: 10.1006/enrs.1997.3770
  27. Luo S, Liu X, Mu S, Tsai SP, Wen CP. Asbestos related diseases from environmental exposure to crocidolite in Da-yao, China. I. Review of exposure and epidemiological data. Occup Environ Med. 2003; 60(1): 35–41; discussion 412. DOI: 10.1136/oem.60.1.35
  28. Gao Z, Hiroshima K, Wu X, et al. Asbestos textile production linked to malignant peritoneal and pleural mesothelioma in women: Analysis of 28 cases in Southeast China. Am J Ind Med. 2015; 58(10): 10401049. DOI: 10.1002/ajim.22494
  29. Torres-Roman JS, Gomez-Rubio V, Sanchez-Trujillo L, et al. Geographic study of mortality due to mesothelioma in Peru and its evolution. Cancer Epidemiol. 2020; 68: 101791. DOI: 10.1016/j.canep.2020.101791
  30. Kwak KM, Paek D, Hwang SS, Ju YS. Estimated future incidence of malignant mesothelioma in South Korea: Projection from 2014 to 2033. PLoS One. 2017; 12(8): e0183404. DOI: 10.1371/journal.pone.0183404
  31. Baumann F, Rougier Y, Ambrosi JP, Robineau BP. Pleural mesothelioma in New Caledonia: an acute environmental concern. Cancer Detect Prev. 2007; 31(1): 7076. DOI: 10.1016/j.cdp.2006.10.009
  32. Baumann F, Maurizot P, Mangeas M, Ambrosi JP, Douwes J, Robineau B. Pleural mesothelioma in New Caledonia: associations with environmental risk factors. Environ Health Perspect. 2011; 119(5): 695700. DOI: 10.1289/ehp.1002862
  33. Wilk E, Krówczyńska M. Malignant mesothelioma and asbestos exposure in Europe: Evidence of spatial clustering. Geospat Health. 2021; 16(1). DOI: 10.4081/gh.2021.951
  34. Vimercati L, Cavone D, Delfino MC, et al. Asbestos Air Pollution: Description of a Mesothelioma Cluster Due to Residential Exposure from an Asbestos Cement Factory. Int J Environ Res Public Health. 2020; 17(8). DOI: 10.3390/ijerph17082636
  35. Angelini A, Chellini E, Parducci D, Puccetti M, Mauro L. Reconstruction of the asbestos exposure in a textile company producing sewing threads through the use of an unusual information source. Med Lav. 2020; 111(2): 126132. DOI: 10.23749/mdl.v111i2.8837
  36. Mensi C, Riboldi L, De Matteis S, Bertazzi PA, Consonni D. Impact of an asbestos cement factory on mesothelioma incidence: global assessment of effects of occupational, familial, and environmental exposure. Environ Int. 2015; 74: 191199. DOI: 10.1016/j.envint.2014.10.016
  37. Ascoli V, Romeo E, Carnovale Scalzo C, et al. Familial malignant mesothelioma: A population-based study in Central Italy (1980–2012). Cancer Epidemiol. 2014; 38(3): 273278. DOI: 10.1016/j.canep.2014.02.014
  38. Corfiati M, Scarselli A, Binazzi A, et al. Epidemiological patterns of asbestos exposure and spatial clusters of incident cases of malignant mesothelioma from the Italian national registry. BMC Cancer. 2015; 15: 286. DOI: 10.1186/s12885-015-1301-2
  39. Fazzo L, Minelli G, De Santis M, et al. Epidemiological surveillance of mesothelioma mortality in Italy. Cancer Epidemiol. 2018; 55: 184191. DOI: 10.1016/j.canep.2018.06.010
  40. Zona A, Fazzo L, Minelli G, et al. Peritoneal mesothelioma mortality in Italy: Spatial analysis and search for asbestos exposure sources. Cancer Epidemiol. 2019; 60: 162167. DOI: 10.1016/j.canep.2019.04.001
  41. Marinaccio A, Binazzi A, Marzio D Di, et al. Pleural malignant mesothelioma epidemic: incidence, modalities of asbestos exposure and occupations involved from the Italian National Register. Int J Cancer. 2012; 130(9): 21462154. DOI: 10.1002/ijc.26229
  42. McElvenny DM, Darnton AJ, Price MJ, Hodgson JT. Mesothelioma mortality in Great Britain from 1968 to 2001. Occup Med (Lond). 2005; 55(2): 7987. DOI: 10.1093/occmed/kqi034
  43. Musk AWB, Reid A, Olsen N, et al. The Wittenoom legacy. Int J Epidemiol. 2020; 49(2): 467476. DOI: 10.1093/ije/dyz204
  44. Hansen J, De Klerk NH, Eccles JL, William Musk A, Hobbs MST. Malignant mesothelioma after environmental exposure to blue asbestos. Int J Cancer. 1993; 54(4): 578581. DOI: 10.1002/ijc.2910540410
  45. Hansen J, de Klerk NH, Musk AW, Hobbs MS. Environmental exposure to crocidolite and mesothelioma: exposure-response relationships. Am J Respir Crit Care Med. 1998; 157(1): 6975. DOI: 10.1164/ajrccm.157.1.96-11086
  46. Reid A, Heyworth J, de Klerk NH, Musk B. Cancer incidence among women and girls environmentally and occupationally exposed to blue asbestos at Wittenoom, Western Australia. Int J Cancer. 2008; 122(10): 23372344. DOI: 10.1002/ijc.23331
  47. Rogers A, Nevill M. Occupational and environmental mesotheliomas due to crocidolite mining activities in Wittenoom, Western Australia. Scand J Work Environ Health. 1995; 21(4): 259264. DOI: 10.5271/sjweh.35
  48. Emmett EA. Asbestos in High-Risk Communities: Public Health Implications. Int J Environ Res Public Health. 2021; 18(4). DOI: 10.3390/ijerph18041579
  49. van Gerwen M, Alpert N, Flores R, Taioli E. An overview of existing mesothelioma registries worldwide, and the need for a US Registry. Am J Ind Med. 2020; 63(2): 115120. DOI: 10.1002/ajim.23069
  50. Rojas L, Cardona AF, Trejo-Rosales R, et al. Characteristics and long-term outcomes of advanced pleural mesothelioma in Latin America (MeSO-CLICaP). Thorac Cancer. 2019; 10(3): 508518. DOI: 10.1111/1759-7714.12967
  51. Rojas L. Personal Communication. Rojas L. Personal Communication. December 21, 2021
  52. Baris YI, Sahin AA, Ozesmi M, et al. An outbreak of pleural mesothelioma and chronic fibrosing pleurisy in the village of Karain/Urgüp in Anatolia. Thorax. 1978; 33(2): 181192. DOI: 10.1136/thx.33.2.181
  53. Sahin U, Ozturk O, Songur N, Bircan A, Akkaya A. Observations on environmental asbestos exposure in a high risk area. Respirology. 2009; 14(4): 579582. DOI: 10.1111/j.1440-1843.2009.01493.x
  54. Metintas M, Özdemir N, Hillerdal G, et al. Environmental asbestos exposure and malignant pleural mesothelioma. Respir Med. 1999; 93(5): 349355. DOI: 10.1016/S0954-6111(99)90318-9
  55. U.S. Human Department of Health and Human Services. The Belmont Report – Ethical Principles and Guidelines for the Protection of Human Subjects of Research; 1979.
  56. U.S. National Institutes of Health. Guiding Principles for Ethical Research. Accessed December 14, 2022. https://www.nih.gov/health-information/nih-clinical-research-trials-you/guiding-principles-ethical-research.
  57. Breslow NE, Day NE. Statistical Methods in Cancer Research Volume II: The Design and Analysis of Cohort Studies. 82nd ed. IARC Scientific Publication; 1986.
  58. Esteve J, Benhamou E, Raymond L. Statistical Methods in Cancer Research Volume IV: Descriptive Epidemiology. 128th ed. IARC Scientific Publication; 1994.
  59. Mullan RJ, Murthy LI. Occupational Sentinel Health Events: An up-Dated List for Physician Recognition and Public Health Surveillance. Am J Ind Med. 1991; 19: 775799. DOI: 10.1002/ajim.4700190610
  60. Bray F, Colombet M, Mery L, et al. Cancer Incidence in Five Continents, Vol. XI (electronic version). Published 2017. Accessed February 2, 2023. https://ci5.iarc.fr/Default.aspx.
  61. Mesothelioma National Register. Guidelines for the Identification and Definition of Malignant Mesothelioma Cases and the Transmission to ISPESL by Regional Operating Centres. Published online 2002.
  62. Taylor BH, Warnock C, Tod A. Communication of a mesothelioma diagnosis: developing recommendations to improve the patient experience. BMJ Open Respir Res. 2019; 6(1): e000413. DOI: 10.1136/bmjresp-2019-000413
  63. Marsili D, Magnani C, Canepa A, et al. Communication and health education in communities experiencing asbestos risk and health impacts in Italy. Ann Ist Super Sanita. 2019; 55(1): 7079. DOI: 10.4415/ANN_19_01_14
  64. Granieri A. Community exposure to asbestos in Casale Monferrato: from research on psychological impact to a community needs-centered healthcare organization. Ann Ist Super Sanità. 2015; 51(4): 336341. DOI: 10.4415/ANN_15_04_14
  65. WHO. Emergency Risk Communication Training.
  66. Colombian Ministry of Health. Resolución 8430 de 1993.
  67. Colombian Ministry of Health. SISPRO Sistema Integral de Información de la Protección Social. Published 2015. Accessed February 2, 2023. http://www.sispro.gov.co/.
  68. Forman D, Bray F, Brewster DH, et al. Cancer Incidence in Five Continents Vol. X. 164th ed. IARC Scientific Publication; 2014.
  69. Nuyts V, Nawrot T, Nemery B, Nackaerts K. Hotspots of malignant pleural mesothelioma in Western Europe. Transl Lung Cancer Res. 2018; 7(5): 516519. DOI: 10.21037/tlcr.2018.10.01
  70. Krówczyńska M, Wilk E, Pabjanek P, Olędzka G. Pleural mesothelioma in Poland: Spatial analysis of malignant mesothelioma prevalence in the period 1999–2013. Geospat Health. 2018; 13(2): 314321. DOI: 10.4081/gh.2018.667
  71. Tamura A, Funakoshi M, Naw Awn J-P, et al. Potential asbestos exposure among patients with primary lung cancer in Japan. 2018; 60(3): 236245. DOI: 10.1539/joh.2017-0199-OA
  72. Noonan CW. Environmental asbestos exposure and risk of mesothelioma. Ann Transl Med. 2017; 5(11): 111. DOI: 10.21037/atm.2017.03.74
DOI: https://doi.org/10.5334/aogh.4166 | Journal eISSN: 2214-9996
Language: English
Submitted on: May 5, 2023
Accepted on: Sep 9, 2023
Published on: Oct 4, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2023 Juan Pablo Ramos-Bonilla, Margarita Giraldo, Daniela Marsili, Roberto Pasetto, Benedetto Terracini, Agata Mazzeo, Corrado Magnani, Pietro Comba, Benjamin Lysaniuk, María Fernanda Cely-García, Valeria Ascoli, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.